Flowr Provides Notice of Second Quarter 2019 Results Release and Conference Call Details
August 07 2019 - 04:45PM
The Flowr Corporation (TSXV: FLWR; OTC: FLWPF) (“Flowr” or the
“Company”) announced today that it will release its second
quarter 2019 results after the close of the financial markets on
Thursday, August 15, 2019, which will be followed by a conference
call and webcast to review these results at 5:30 p.m. Eastern Time.
Conference call and webcast details are as
follows:
Toll Free: 1-877-705-6003Toll/International:
1-201-493-6725Webcast: flowr.ca/investors
Conference call replay details are as
follows:
Toll Free: 1-844-512-2921Toll/International:
1-412-317-6671Passcode:
13693091Webcast: flowr.ca/investors
The replay of the conference call will be
available through midnight on Thursday, August 29, 2019.
About The Flowr Corporation
Flowr, through its subsidiaries, holds a
cannabis production and sales license granted by Health Canada.
With a head office in Toronto and a production facility in Kelowna,
BC, Flowr builds and operates large-scale, GMP-designed cultivation
facilities utilizing its own growing systems. Flowr’s investment in
research and development along with its sense of craftsmanship and
a spirit of innovation is expected to enable it to provide
premium-quality cannabis that appeals to the adult-use recreational
market and addresses specific patient needs in the medicinal
market.
For more information, visit flowr.ca. Follow
Flowr on Twitter: @FlowrCanada; Facebook: Flowr Canada; Instagram:
@flowrcanada; and LinkedIn: The Flowr Corporation.
On behalf of The Flowr Corporation:Vinay
ToliaCEO and Director
CONTACT INFORMATION:
MEDIA: Sean GriffinVice President, Communications & Public
Relations(877) 356-9726 ext. 1526sean.griffin@flowr.ca
INVESTORS:Thierry ElmalehHead of Capital Markets(877) 356-9726
ext. 1528thierry@flowr.ca
Forward-Looking Information and
Statements
This press release includes forward-looking
information within the meaning of Canadian securities laws
regarding Flowr and its business, which may include, but are not
limited to: statements with respect to the release date of Flowr's
financial results, Flowr’s investment in research and
development along with its sense of craftsmanship and a spirit of
innovation enabling it to provide premium-quality cannabis that
appeals to the adult-use recreational market and address specific
patient needs in the medicinal market and other factors.
Often, but not always, forward-looking information can be
identified by the use of words such as “plans”, “is expected”,
“expects”, “scheduled”, “intends”, “contemplates”, “anticipates”,
“believes”, “proposes” or variations (including negative and
grammatical variations) of such words and phrases, or state that
certain actions, events or results “may”, “could”, “would”, “might”
or “will” be taken, occur or be achieved. Such statements are based
on the current expectations of Flowr’s management and are based on
assumptions and subject to risks and uncertainties. Although
Flowr’s management believes that the assumptions underlying these
statements are reasonable, they may prove to be incorrect. The
forward-looking events and circumstances discussed in this press
release may not occur by certain specified dates or at all and
could differ materially as a result of known and unknown risk
factors and uncertainties affecting Flowr, including risks
associated with a delay in releasing Flowr’s financial
statements (which could result in a violation of applicable
laws), Flowr not being able to sustain its competitive advantage in
cultivation and being unable to remain at the forefront of industry
innovation, whether as a result of failed construction of the
facilities or otherwise, Flowr not being able to meet demand or
fulfill purchase orders, which could materially impact revenues and
its relationships with purchasers, Flowr requiring additional
financing from time to time in order to continue its operations and
such financing may not be available when needed or on terms and
conditions acceptable to the Company, new laws or regulations
adversely affecting the Company’s business and results of
operations, results of operation activities and development of
projects, project cost overruns or unanticipated costs and
expenses, the inability of Flowr’s products to be high quality, the
inability of Flowr’s products to appeal to the adult-use
recreational market and address specific patient needs in the
medicinal market, the inability of Flowr to produce and distribute
premium, high quality products, the inability to supply products or
any delay in such supply, Flowr’s securities, the inability to
generate cash flows, revenues and/or stable margins, the inability
to grow organically, risks associated with the geographic markets
in which Flowr operates and/or distributes its products, risks
associated with fluctuations in exchange rates (including, without
limitation, fluctuations in currencies), risks associated with the
use of Flowr’s products to treat certain conditions, the cannabis
industry and the regulation thereof, the failure to comply with
applicable laws, risks relating to partnership arrangements,
possible failure to realize the anticipated benefits of partnership
arrangements, product launches (including, without limitation,
unsuccessful product launches), the inability to launch products,
the failure to obtain regulatory approvals, economic factors,
market conditions, risks associated with the acquisition and/or
launch of products, the equity and debt markets generally, risks
associated with growth and competition (including, without
limitation, with respect to Flowr’s products), general economic and
stock market conditions, risks and uncertainties detailed from time
to time in Flowr’s filings with the Canadian Securities
Administrators and many other factors beyond the control of
Flowr. Although Flowr has attempted to identify important
factors that could cause actual actions, events or results to
differ materially from those described in forward-looking
information, there may be other factors that cause actions, events
or results to differ from those anticipated, estimated or intended.
No forward-looking information can be guaranteed. Except as
required by applicable securities laws, forward-looking information
speaks only as of the date on which it is made and Flowr undertakes
no obligation to publicly update or revise any forward-looking
information, whether as a result of new information, future events,
or otherwise.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this press release.
The Flowr (TSXV:FLWR)
Historical Stock Chart
From Feb 2024 to Mar 2024
The Flowr (TSXV:FLWR)
Historical Stock Chart
From Mar 2023 to Mar 2024